Intratumoral CAN2109 in Subjects With Solid Tumors

Clinical trial NCT06332430 · RECRUITING

Trial details

NCT number: NCT06332430
Sponsor: Canwell Biotech Limited
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Lymphoma

Start date: 2024-05-28
Primary completion: 2025-05-30
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.